Prebiotics and gastrointestinal health

Prebiotics and gastrointestinal health


Kevin Whelan


King’s College London, London, UK


The composition of the gastrointestinal (GI) microbiota is dramatically influenced by diet, with the first description of differences in the numbers of luminal bifidobacteria between breastfed and formula-fed infants occurring in the late 1800s [1]. However, the ability of certain dietary constituents to impact specifically on the GI microbiota, the mechanisms through which they do so, and the potential clinical application for the management of disease have only recently been explored in depth.


Habitual long-term diet has been shown to strongly associate with different clusters of bacteria in the colon, termed ‘enterotypes’. For example, high intakes of protein and animal fat are associated with the Bacteroides enterotype and high intakes of carbohydrate are associated with the Prevotella enterotype [2]. In terms of short-term dietary changes, acute feeding studies show that altering fat and non-starch polysaccharide intakes alters the microbiota but does not change these enterotypes [3].


Many exogenous dietary components, as well as endogenous material (e.g. sloughed enterocytes, red blood cells), are metabolised by the GI microbiota through fermentation and produce short-chain fatty acids (SCFA). The main dietary substrates that undergo bacterial metabolism are non-digestible carbohydrates that escape digestion and absorption in the upper GI tract (commonly termed dietary fibre), including non-starch polysaccharides (e.g. pectins, guar gum, hemicellulose), non-digestible oligosaccharides (e.g. fructans, galactans) and resistant starch, in addition to some disaccharides and monosaccharides that are conditionally non-digestible (e.g. in lactose maldigestion, fructose maldigestion). Many of these non-digestible carbohydrates are substrates for bacterial fermentation and therefore support the growth of a wide range of bacteria in the GI tract. However, since 1995, extensive research has demonstrated that some non-digestible carbohydrates stimulate specific microbiota (e.g. bifidobacteria) and these are termed prebiotics [4].


2.4.1 Prebiotic definitions, characteristics and classes


Prebiotics are non-digestible, fermentable food components that result in ‘the selective stimulation of growth and/or activity of one or a limited number of microbial genera/species in the GI microbiota that confer health benefits to the host’ [5]. This is the most recent definition and updates earlier versions to account for the fact that prebiotics can influence the activity, as well as the numbers, of specific bacteria.


There are three essential characteristics of a prebiotic: (i) its resistance to digestion in the upper GI tract; (ii) its ability to be fermented by the host microbiota; and (iii) for this to impact on the growth or activity of specific bacteria only [5]. Resistance to small intestinal digestion is the result of humans lacking enzymes that hydrolyse the various polymer bonds. This allows the prebiotic to reach the colon intact and undergo fermentation, but only by a limited number of genera/species.


The most common classes of prebiotics are inulin-type fructans (e.g. inulin, oligofructose, fructo-oligosaccharides) and galactans (galacto-oligosaccharides, e.g. stachyose, raffinose) (Table 2.4.1). Lactulose, the synthetic non-digestible carbohydrate used as an osmotic laxative for constipation, is also a prebiotic but is rarely used in functional food preparations and therefore is not reviewed here. The potential prebiotic properties of other novel oligosaccharides (e.g. isomalto-oligosaccharides, soybean oligosaccharides) are also under investigation.


Table 2.4.1 Selection of compounds with proven prebiotic properties










































Generic name Class Common source and manufacture Degree of polymerisation (DP)
Range Average
Inulin (mixed length) Inulin-type fructan (ITF) Extracted from chicory or other sources 2–60 12
Inulin (high molecular weight) Inulin-type fructan Physical purification of inulin from chicory 10–60 25
Fructo-oligosaccharides (FOS) Inulin-type fructan Generally from enzymatic synthesis from sucrose 2–9 3.6
Oligofructose (OF) Inulin-type fructan Generally from partial enzymatic hydrolysis of inulin 2–9 4
Galacto-oligosaccharides (GOS) or trans-GOS Galactans Enzymatic transgalactosylation of lactose 2–9

Inulin-type fructans (ITF) consist of linear polymers of fructose monomers joined by beta(2 → 1) linkages, some of which also have a terminal glucose monomer. The major ITFs are inulin, oligofructose (OF) and fructo-oligosaccharides (FOS), which are defined based upon their source and the number of monomers in the polymer chain (degree of polymerisation, DP) (see Table 2.4.1). In general, inulin has a wide-ranging polymer length (DP 2–60), whereas OF and FOS have a shorter length (DP 2–10) [5]. Inulin-type fructans are found in very large amounts in chicory root (35.7–47.6 g/100 g), which is the most common source for commercial preparations of inulin, but is also present in Jerusalem artichoke (16–20 g/100 g) and garlic (9–16 g/100 g) [6]. ITFs are found in small amounts in cereals such as wheat (1–4 g/100 g), which is actually the most common dietary source in the United Kingdom [7] and the United States due to its widespread consumption.


Galactans include the prebiotics galacto-oligosaccharides (GOS), which are short polymers (DP usually <10) of galactose monomers joined by beta(1 → 6), beta(1 → 3) and/or beta(1 → 4) linkages to a terminal glucose monomer [9]. Galacto-oligosaccharides are widely contained and consumed within pulses, where the type of linkages may differ.


2.4.2 Evidence of selective stimulation of gastrointestinal microbiota


The first key human study to demonstrate the prebiotic effect compared the impact of 15 g/day of oligofructose or inulin, in a randomized, cross-over trial of eight healthy people consuming a controlled diet. Both compounds resulted in almost a 1 log10 increase in luminal bifidobacteria [10].


Many in vitro, animal, human and even some clinical studies have now demonstrated the ability of ITFs and GOS to stimulate the growth of bifidobacteria (the prebiotic effect), and these have been extensively reviewed and tabulated elsewhere [5]. Indeed, some studies in healthy humans have also shown increases in other bacteria including lactobacilli [10] and Faecalibacterium prausnitzii [11]. Although not frequently investigated in vivo, the increase in bifidobacteria following prebiotic supplementation (sometimes referred to as bifidogenesis) has been shown to be at the expense of a range of other bacteria including reductions in clostridia [10]and bacteroides [12]. Interestingly, the majority of prebiotic studies use supplements and the effect of prebiotics naturally occurring in foods has received little attention in the literature. Therefore, the effects of a diet high in ITFs (e.g. chicory, onion, wheat) and GOS (e.g. beans, pulses) are as yet unclear.


The mechanism of how prebiotics are able to selectively stimulate the growth of specific bacteria has until recently received little attention in the literature. In one study it was shown that some bacteria have ‘fructan utilisation locus’ genes that enable them to acquire and ferment ITFs [13]. Studies in mice have shown that the functional expression of the ‘fructan utilisation locus’ in different bacteria was highly predictive of the ability of that strain to be selectively stimulated when the mice were fed inulin [13]. Therefore it is thought that during prebiotic supplementation, bacteria with the ability to express genes coding for fructan utilisation are better able to access the carbon source in the ITF, use it for bacterial metabolism and therefore are better able to proliferate, a process of competitive selection.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 30, 2016 | Posted by in GASTROENTEROLOGY | Comments Off on Prebiotics and gastrointestinal health

Full access? Get Clinical Tree

Get Clinical Tree app for offline access